{
    "2021-08-07": [
        [
            {
                "time": "",
                "original_text": "恒瑞医药VS复星医药：时移境迁 殊途同向未了局",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "复星医药",
                        "时移境迁",
                        "殊途同向"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "又一百亿级私有化交易案诞生：香港“财爷”梁锦松、复星华平高盛都来了",
                "features": {
                    "keywords": [
                        "私有化",
                        "复星",
                        "梁锦松",
                        "高盛"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "高研发投入，是这些创新药企发展基石",
                "features": {
                    "keywords": [
                        "高研发投入",
                        "创新药企",
                        "发展基石"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "锂电池领跑比亚迪市值暴增 生物疫苗恐高复星医药重挫",
                "features": {
                    "keywords": [
                        "锂电池",
                        "比亚迪",
                        "生物疫苗",
                        "复星医药",
                        "重挫"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "新能源",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "两只千亿“医药大白马”突然暴跌！竟然是机构大举砸盘，发生了什么？",
                "features": {
                    "keywords": [
                        "医药大白马",
                        "暴跌",
                        "机构砸盘"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}